I have been following RAC and have been accumulating shares for the last 2 months and plan to continue. Just want to thank all the major contributors to this forum especially wombat777 and Mason14.
I
With the trial announced (and knowing the high probability of success due to historical trials and data) RAC is on a clear path to successfully execute its strategy. As we know there are risks associated with everything in life. Assuming the trials play out as expected what are the biggest risks to RAC achieving a buyout. A few I can think of:
1. A competitor get to market first or develops a more effective drug - from what I have read on this is highly unlikely due to the head start RAC has due to historical trials/data
2. Issues with patents - I do not know enough about this space to comment
3. Data gathered by RAC does not achieve the desired interest from big Pharma - Unlikely due to the experience management team
Would appreciate feedback.
Thanks
I have been following RAC and have been accumulating shares for...
-
- There are more pages in this discussion • 60 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.65 |
Change
-0.040(2.37%) |
Mkt cap ! $281.2M | |||
| Open | High | Low | Value | Volume |
| $1.69 | $1.69 | $1.64 | $50.53K | 30.36K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 539 | $1.65 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.69 | 731 | 1 |
View Market Depth
| Last trade - 16.10pm 07/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |